ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Maria Sklodowska-Curie National Research Institute of Oncology at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Maria Sklodowska-Curie National Research Institute of Oncology takes part in 12 sessions at ESMO 2026 in Madrid. Its work spans breast cancer, sarcoma, melanoma, and lung cancer, with attention to treatment safety and biomarkers. Specific studies examine drug-related side effects in breast cancer and treatment approaches for early melanoma.
| Organization | ESMO 2026 Attendance |
|---|---|
MS Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland | |
National cancer research institute and hospital in Warsaw, Poland, with branches in Kraków and Gliwice. | Poster Fri Oct 23 13:00–15:00 Health-related quality of life (HRQoL) during neoadjuvant treatment with eftilagimod alfa, pembrolizumab and radiotherapy in patients with soft tissue sarcoma (STS): Results from EFTISARC-NEO trial Sarcoma, CNS, head & neck and rare cancersNursing & supportive care Poster Fri Oct 23 13:00–15:00 Immune-related adverse events as on-treatment markers of response to pembrolizumab in early triple-negative breast cancer: A systematic review and meta-analysis Breast cancerBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Real-world BRCA1/2 testing patterns in early breast cancer in the era of adjuvant CDK4/6 inhibitors Breast cancerBiomarkers & precision oncology Chair Fri Oct 23 16:15–17:45 Rapid oral 1: Gastrointestinal tumour, upper digestive Gastrointestinal cancers Abstract Fri Oct 23 17:24–17:36 Invited Discussant 2879RO, 3136RO and 2883RO Gastrointestinal cancers Poster Sat Oct 24 12:00–12:45 Talk Sat Oct 24 12:12–12:19 Satellite Sat Oct 24 14:45–15:05 Dermatological care in EGFR-mutated NSCLC: balancing efficacy and skin tolerabilit Lung & thoracic cancersNursing & supportive care Talk Sat Oct 24 16:30–16:45 Poster Sun Oct 25 12:00–12:45 Chair Sun Oct 25 14:45–16:00 More cures in early melanoma Melanoma & skin cancers Talk Sun Oct 25 14:50–15:10 Surgery, sentinels and adjuvant approaches Melanoma & skin cancers Poster Mon Oct 26 12:00–12:45 Detailed safety analysis of varegacestat treatment for desmoid tumors in the RINGSIDE phase 3 trial Sarcoma, CNS, head & neck and rare cancers |
Find decision makers at Maria Sklodowska-Curie National Research Institute of Oncology
Tell us what you sell and we’ll find the people at Maria Sklodowska-Curie National Research Institute of Oncology most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction